<DOC>
	<DOCNO>NCT00206115</DOCNO>
	<brief_summary>The purpose 6-week study determine whether treatment Seroquel® Sustained Release ( SR ) effective placebo treatment acute schizophrenia . PLEASE NOTE : Seroquel SR Seroquel XR refer formulation . The SR designation change XR consultation FDA .</brief_summary>
	<brief_title>SR-Registration Study 1 , ROW : Efficacy Safety Seroquel® Treatment Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>To consider study patient age 18 65 year , need suffer schizophrenia must willing participate . Patients suffer psychiatric disorder schizophrenia include drug abuse dependence , medical condition specific kidney , heart thyroid problem , patient know lack response drug schizophrenia consider study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Schizophrenic disorder</keyword>
</DOC>